MedLab Middle East will take place in Dubai from 5 to 8 February 2024.
Immunochromatography tests, or rapid tests, are a type of rapid diagnostic test based on the detection of the presence or absence of certain substances in a biological sample (blood, urine or saliva, among others). The process involves the capture of particles bound to specific antibodies or antigens that pass through a membrane, on which specific antibodies or antigens have also been immobilized, allowing the quick and easy detection of the presence or absence of the target substance in the sample.
These tests are ideal for application in clinics and other points of patient care because they allow results to be obtained quickly and reliably. In addition, their simplicity means that no equipment or specifically trained personnel are required, so that the patient is able to leave the clinic with an indicative diagnosis after the test.
For all these reasons, rapid tests are a great tool to determine whether more expensive and invasive subsequent tests are necessary, and they can be used as a guide to orientate the patient’s diagnosis and management. thus avoiding the prescription of drugs or invasive tests in situations where they are not necessary.
Molecular diagnostic tests are used to detect the presence of genetic material, such as DNA or RNA, in a biological sample susceptible to a disease-related gene or pathogen related to a disease.
These tests use molecular techniques that allow amplification of the genetic material present in the sample in order to identify what is to be detected by hybridization of the amplified fragments through specific probes.
There are different methods for hybridization, such as the reverse blot technique of Opegen products, which uses probes immobilized on a membrane to detect up to 24 different sequences in a single test.
In contrast, in the real-time PCR technique, hybridization occurs by the use of fluorophore-labeled probes during the PCR amplification process, allowing the detection of up to 4 different sequences in a single test. This technique is used for the PCR rt products and is quick and easy to perform.
Large scale production of monoclonal antibodies and recombinant antigens for the immunoassays industry and clinical research.
Highest quality
More than 40 years of experience
Large-scale manufacturing up to hundreds of grams
Optimum batch-to-batch consistency
Tell us about it!
Do you have a prototype test and would like to be able to manufacture it on a large scale, but you do not have enough resources? Is the path to market too complex and threatening to stall your project? After more than 30 years developing, manufacturing and commercialising rapid diagnostic tests, we put our experience as IVD manufacturers at your service.
OPERON is an Aragonese family company, founded in 1973 in Cuarte de Huerva, which started as a small laboratory dedicated to research and development in the field of immunochemistry. Three years later, the company opened up to the international market and the first product exports took place.
Focused on three key product lines (raw materials, rapid tests and molecular diagnostics), as well as offering a contract manufacturing service, the company has continued to grow and expand its horizons to become a solid reference in the Aragonese biotechnology sector.
OPERON currently employs more than 80 workers, most of them dedicated to R&D, and exports its products to more than 50 countries around the world. Moreover, it works under the strictest quality standards, thus ensuring that its experience becomes the difference you will make in the market.
Experience
Professional team
Worldwide distribution
Committed to
celiac disease
Yesterday took place the XIV Convención de la Asociación de Directivos y Ejecutivos de Aragón, which every year awards the prestigious Premios ADEA and which
LAYING OF THE FOUNDATION STONE OF OUR NEW HEADQUARTERS
Yesterday, Wednesday 4th October, we celebrated the laying of the foundation stone of what will be our new headquarters at Plataforma Logística
UNDERESTIMATION OF PREVALENCE OF S.PNEUMONIAE SEROTYPES MIGHT AFFECT VACCINES PERFORMANCE FOLLOW UP
Prevalence data of Streptococcus pneumoniae serotypes in pleural infections may be underestimated when surveillance is only based in culture and conventional phenotypic
INCLUSION OF THE HPV VACCINE IN BOYS IN THE SPANISH VACCINE SCHEDULE
One of the main demands of doctors for years has been that the Human Papilloma Virus (HPV) vaccine -responsible for 90% of
